Clorox Positioned For Comeback: Analyst Predicts Earnings Beats And 3-Year Growth Surge, Upgrades Stock
Portfolio Pulse from Nabaparna Bhattacharya
Jefferies analyst Kaumil Gajrawala upgraded Clorox Company (NYSE:CLX) to Buy, raising the price target to $187. The analyst predicts Clorox will achieve earnings beats and a 3-year growth surge, driven by improved topline growth and operating leverage. Clorox aims for a 3-5% organic sales CAGR through fiscal 2028.
October 01, 2024 | 6:48 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jefferies upgraded Clorox to Buy, raising the price target to $187. The analyst forecasts earnings beats and a 3-year growth surge, driven by improved topline growth and operating leverage.
The upgrade from Jefferies and the raised price target indicate positive sentiment and expected performance improvements for Clorox. The analyst's forecast of earnings beats and growth surge suggests a likely positive impact on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100